With a robust medical-phase pipeline, Agenus harnesses a mix of proprietary antibody platforms, for example Retrocyte Display™ and SECANT®, and impressive mobile therapy techniques, positioning alone being a critical contributor during the biotechnology and immunotherapy arena.These built-in technologies allow for for the development of each one